Dosing regimens for treating and/or preventing cerebral amyloidoses
US9675627B2 · kind B2 · utility
0Cited by
0References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 13, 2015 |
| Grant date | Jun 13, 2017 |
| Priority date | — |
| Expiry date | Apr 13, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are dosing regimens and kits for the treatment and/or prevention of cerebral amyloidoses such as Alzheimer's disease (AD) and/or cerebral amyloid angiopathy (CAA).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.